Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

A comparative costs analysis of brachytherapy and radical retropubic prostatectomy therapies for clinically localized prostate cancer.

Gianino MM, Galzerano M, Minniti D, Di Novi C, Martin B, Davini O, Barbaro S.

Int J Technol Assess Health Care. 2009 Jul;25(3):411-4. doi: 10.1017/S0266462309990043. Review.

PMID:
19619361
2.

Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer.

Ciezki JP, Klein EA, Angermeier KW, Ulchaker J, Zippe CD, Wilkinson DA.

Urology. 2000 Jan;55(1):68-72.

PMID:
10654897
3.
4.

Cost comparison of curative therapies for localized prostate cancer in Japan: a single-institution experience.

Satoh T, Ishiyama H, Matsumoto K, Tabata K, Kitano M, Iwamura M, Kimura M, Minamida S, Yamashita H, Matsuda D, Kotani S, Niibe Y, Uemae M, Hayakawa K, Baba S.

Jpn J Radiol. 2009 Nov;27(9):348-54. doi: 10.1007/s11604-009-0356-x. Epub 2009 Nov 27.

PMID:
19943145
5.

Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience.

Silverstein AD, Weizer AZ, Dowell JM, Auge BK, Paulson DF, Dahm P.

Urology. 2004 Apr;63(4):746-50.

PMID:
15072893
6.

Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.

Norderhaug I, Dahl O, Høisaeter PA, Heikkilä R, Klepp O, Olsen DR, Kristiansen IS, Waehre H, Bjerklund Johansen TE.

Eur Urol. 2003 Jul;44(1):40-6. Review.

PMID:
12814673
7.

Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study.

Giberti C, Chiono L, Gallo F, Schenone M, Gastaldi E.

World J Urol. 2009 Oct;27(5):607-12. doi: 10.1007/s00345-009-0418-9. Epub 2009 May 20.

PMID:
19455340
8.

Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies.

Ficarra V, Novara G, Artibani W, Cestari A, Galfano A, Graefen M, Guazzoni G, Guillonneau B, Menon M, Montorsi F, Patel V, Rassweiler J, Van Poppel H.

Eur Urol. 2009 May;55(5):1037-63. doi: 10.1016/j.eururo.2009.01.036. Epub 2009 Jan 25. Review.

PMID:
19185977
9.

Perioperative costs and charges of prostate brachytherapy and prostatectomy.

Makhlouf AA, Boyd JC, Chapman TN, Theodorescu D.

Urology. 2002 Oct;60(4):656-60.

PMID:
12385928
10.

Cost comparison of laparoscopic versus radical retropubic prostatectomy.

Anderson JK, Murdock A, Cadeddu JA, Lotan Y.

Urology. 2005 Sep;66(3):557-60.

PMID:
16140077
11.

A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer.

Hashine K, Kusuhara Y, Miura N, Shirato A, Sumiyoshi Y, Kataoka M.

Jpn J Clin Oncol. 2008 Jul;38(7):480-5. doi: 10.1093/jjco/hyn059. Epub 2008 Jul 11.

PMID:
18621847
12.

Prospective longitudinal comparative study of health-related quality of life in patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.

Kobuke M, Saika T, Nakanishi Y, Ebara S, Manabe D, Uesugi T, Nose H, Arata R, Tsushima T, Nasu Y, Kumon H.

Acta Med Okayama. 2009 Jun;63(3):129-35.

13.

Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.

Eldefrawy A, Katkoori D, Abramowitz M, Soloway MS, Manoharan M.

Urol Oncol. 2013 Jul;31(5):576-80. doi: 10.1016/j.urolonc.2011.04.005. Epub 2011 May 25.

PMID:
21616691
14.

Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.

Guedea F, Ferrer M, Pera J, Aguiló F, Boladeras A, Suárez JF, Cunillera O, Ferrer F, Pardo Y, Martínez E, Ventura M.

Clin Transl Oncol. 2009 Jul;11(7):470-8.

PMID:
19574206
15.

Local cost structures and the economics of robot assisted radical prostatectomy.

Scales CD Jr, Jones PJ, Eisenstein EL, Preminger GM, Albala DM.

J Urol. 2005 Dec;174(6):2323-9.

PMID:
16280833
16.

Utilizing time-driven activity-based costing to understand the short- and long-term costs of treating localized, low-risk prostate cancer.

Laviana AA, Ilg AM, Veruttipong D, Tan HJ, Burke MA, Niedzwiecki DR, Kupelian PA, King CR, Steinberg ML, Kundavaram CR, Kamrava M, Kaplan AL, Moriarity AK, Hsu W, Margolis DJ, Hu JC, Saigal CS.

Cancer. 2016 Feb 1;122(3):447-55. doi: 10.1002/cncr.29743. Epub 2015 Nov 2.

17.

[Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].

Becerra Bachino V, Cots F, Guedea F, Pera J, Boladeras A, Aguiló F, Suárez JF, Gallo P, Murgui L, Pont A, Cunillera O, Pardo Y, Ferrer M; Grupo Multicéntrico Español de Cáncer de Próstata Organoconfinado..

Gac Sanit. 2011 Jan-Feb;25(1):35-43. doi: 10.1016/j.gaceta.2010.10.008. Spanish.

18.

Alternative therapies for localized prostate cancer.

Beerlage HP.

Curr Urol Rep. 2003 Jun;4(3):216-20. Review.

PMID:
12756085
19.

[The participation experiences of localized prostate cancer patients in the treatment decision-making process].

Chien CH, Chuang CK, Liu KL, Liu HE.

Hu Li Za Zhi. 2007 Feb;54(1):35-42. Chinese.

PMID:
17340546
20.

Costs in surgical techniques for radical prostatectomy: a review of the current state.

Gianino MM, Galzerano M, Martin B, Chiadò Piat S, Gontero P.

Urol Int. 2012;88(1):1-5. doi: 10.1159/000314625. Epub 2010 May 7. Review.

PMID:
20453488

Supplemental Content

Support Center